Enasidenib Mesylate vs Tofacitinib

## Enasidenib Mesylate vs Tofacitinib: Overview

This comparison examines the pharmacological differences between **Enasidenib Mesylate** and **Tofacitinib**.

## Mechanism of Action

**Tofacitinib**: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

## Pharmacokinetics

**Half-life**: Enasidenib Mesylate — N/A; Tofacitinib — 3.2 hours.

## Chemical Properties

**Molecular Formula**: Enasidenib Mesylate — N/A; Tofacitinib — C16H20N6O.

**Molecular Weight**: Enasidenib Mesylate — N/A; Tofacitinib — 312.3700 g/mol.

**Type**: Enasidenib Mesylate — Small molecule; Tofacitinib — Small molecule.